More Articles

Dr Reddy’s launches generic amlodipine/atorvastatin Generics/News | Posted 04/04/2014

Indian generics giant Dr Reddy’s announced on 27 March 2014 the launch of its generic amlodipine/atorvastatin tablets in the US.

European doctors have insufficient knowledge of biosimilars Reports | Posted 28/03/2014

The Alliance for Safe Biologic Medicines (ASBM), which represents patients and physicians, as well as originator biological and biosimilar medicines companies in the US, published results of a surv...

The non-financial benefits of generics substitution Generics/Research | Posted 28/03/2014

Switching between different generic brands of metformin is a good cost-effective approach that does not adversely affect the quality of care for patients with type 2 diabetes, according to the resu...

Indiana biosimilars substitution bill becomes law Policies & Legislation | Posted 28/03/2014

Indiana Governor Mike Pence signed into law on 25 March 2014 legislation that will allow pharmacists to substitute biosimilars that the US Federal Drug Administration (FDA) has approved as intercha...

Biosimilar filgrastim gains Japanese approval Biosimilars/News | Posted 28/03/2014

Sandoz (the generics unit of Novartis) announced on 24 March 2014 that its subsidiary Sandoz Japan had received marketing authorization approval for its biosimilar filgrastim (Filgrastim BS Sandoz).

EMA issues concept paper for revision of immunogenicity guideline Guidelines | Posted 28/03/2014

On 25 March 2013 the European Medicines Agency (EMA) announced the publication of a concept paper to discuss the revision of the guideline on immunogenicity assessment of biotechnology-derived ther...

Anticompetitive practices come under scrutiny in Australia Pharma News | Posted 28/03/2014

The Australian Competition and Consumer Commission (ACCC) has started proceedings in the Federal Court against Pfizer Australia (Pfizer) alleging that offers made by Pfizer to pharmacies before the...

EGA calls for removal of competition and trade barriers for generics Generics/General | Posted 28/03/2014

The European Generic medicines Association (EGA) is calling on the EU to remove barriers to competition and free trade by introducing common sense reforms to European pharmaceutical intellectual pr...